Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
orphan drug
Pharma
Orphan Cures Act dropped from Senate reconciliation bill
The Orphan Cures Act would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 17, 2025 11:30am
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Mar 12, 2025 2:13pm
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
AZ challenges the IRA's 'unintended consequences' with lawsuit
Aug 25, 2023 11:26am
FDA signs off on Sanofi's rare disease drug Xenpozyme
Aug 31, 2022 3:18pm
Sanofi's Dupixent may soon snag a 4th immunology nod
Feb 28, 2022 10:59am
